Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
This randomized phase III trial is studying eflornithine and sulindac to see how well they
work compared to a placebo in preventing colorectal cancer in patients with colon polyps.
Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming
back. The use of eflornithine and sulindac may prevent colorectal cancer. It is not yet known
whether eflornithine and sulindac are more effective than a placebo in preventing colorectal
cancer